OrbiMed’s ADARx Pharmaceuticals ADRX Stock Holding History
Bought
Maintained
Sold
Other funds holding ADRX
SL
OrbiMed's ADRX Position: Q3 2026 in Review
OrbiMed opened a new position in ADARx Pharmaceuticals (ADRX) in Q3 2026: 24,205,789 shares worth $483M. The stake represents 8.78% of the portfolio and ranks #2 among its holdings.
62 funds tracked by Wall St. Rank hold ADRX as of Q3 2026.
- OrbiMed held 24,205,789 shares of ADARx Pharmaceuticals worth $483M as of Q3 2026.
- ADARx Pharmaceuticals was a new OrbiMed position in Q3 2026.
- ADARx Pharmaceuticals made up 8.78% of OrbiMed's portfolio in Q3 2026, its #2 holding.
- 62 funds tracked by Wall St. Rank held ADARx Pharmaceuticals as of Q3 2026.
Based on OrbiMed's 13F filing for Q3 2026, filed 16 Nov 2026.